Literature DB >> 12417434

Astrocyte-induced T cell elimination is CD95 ligand dependent.

Ingo Bechmann1, Barbara Steiner, Ulrike Gimsa, Gil Mor, Susanne Wolf, Martin Beyer, Robert Nitsch, Frauke Zipp.   

Abstract

The brain has an intrinsic capacity to remove infiltrating T cells by inducing apoptosis. However, the pathways and cellular components driving this process are still under debate. Astrocytes seem to play an important role because they colocalize with apoptotic lymphocytes in vivo and induce apoptosis of transformed T cells in vitro. Since we previously demonstrated the expression of the death ligand CD95L (APO-1L/FasL) on astrocytes in the brain, we wanted to know whether nontransformed astrocytes induce cell death in nontransformed T cells, reflecting the in vivo situation and, if so, whether CD95/CD95 ligand interaction is important. T cell apoptosis measured by Annexin V binding and DNA fragmentation was significantly lower using CD95 ligand-deficient (gld) astrocytes compared to nondeficient controls. Moreover, neutralizing anti-CD95 ligand antibody reduced astrocyte-induced T cell apoptosis. Thus, adult astrocytes are capable of inducing the apoptotic death of T cells by involving the CD95/CD95 ligand pathway without undergoing cell death in vitro. Since astrocytic end-feet contribute to the formation of the blood-brain barrier, this depletion mechanism may play an important role as the first line of defense in the brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417434     DOI: 10.1016/s0165-5728(02)00311-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion.

Authors:  Leman Mutlu; Christine Brandt; Erik Kwidzinski; Birgit Sawitzki; Ulrike Gimsa; Jacqueline Mahlo; Orhan Aktas; Robert Nitsch; Marloes van Zwam; Jon D Laman; Ingo Bechmann
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

Review 4.  Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation.

Authors:  Zsuzsanna Fabry; Heidi A Schreiber; Melissa G Harris; Matyas Sandor
Journal:  Curr Opin Pharmacol       Date:  2008-09-02       Impact factor: 5.547

Review 5.  A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.

Authors:  Hila Doron; Tobias Pukrop; Neta Erez
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

Review 6.  Astrocyte roles in traumatic brain injury.

Authors:  Joshua E Burda; Alexander M Bernstein; Michael V Sofroniew
Journal:  Exp Neurol       Date:  2015-03-28       Impact factor: 5.330

Review 7.  Interaction of astrocytes and T cells in physiological and pathological conditions.

Authors:  Luokun Xie; Shao-Hua Yang
Journal:  Brain Res       Date:  2015-03-23       Impact factor: 3.252

8.  Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

Authors:  Andrew J Steelman; Roger Smith; C Jane Welsh; Jianrong Li
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 9.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

10.  Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152).

Authors:  Ulrike Gimsa; Anita ØRen; Pushpa Pandiyan; Daniela Teichmann; Ingo Bechmann; Robert Nitsch; Monika C Brunner-Weinzierl
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.